The herbal composition GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica reduces obesity via skeletal muscle AMPK and PPARα

Pharmaceutical Biology

Volumn 50, Issue 4, 2012, Pages 506-515

  Shin, Soon Shik ^a   Park, Dongmin ^b   Lee, Hee Young ^a   Hong, Yeonhee ^b   Choi, Jeonghyun ^b   Oh, Jaeho ^b   Lee, Hyunghee ^b   Lee, Hye Rim ^a   Kim, Mi Ryeo ^c   Shen, Zhi Bin ^d   Cui, Hong Hua ^d   Yoon, Michung ^b  

^a Dong Eui University   (South Korea)

^b Mokwon University   (South Korea)

^c Daegu Haany University   (South Korea)

^d GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

AMPK; C2C12; Fatty acid oxidation; GGEx18; Obesity; PPAR ; Skeletal muscle

Indexed keywords

AMP ACTIVATED PROTEIN KINASE ALPHA 1; AMP ACTIVATED PROTEIN KINASE ALPHA 2; ANTIOBESITY AGENT; CARNITINE PALMITOYLTRANSFERASE I; GYEONGSHINGANGJEEHWAN 18; HERBACEOUS AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; MESSENGER RNA; OXIDOREDUCTASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 3; VERY LONG CHAIN ACYL COENZYME A DEHYDROGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EPHEDRA SINICA; FATTY ACID OXIDATION; GENE; GENE ACTIVATION; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LAMINARIA; LAMINARIA JAPONICA; LIPID STORAGE; LIPOLYSIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA GENE; RHUBARB; SKELETAL MUSCLE; WEIGHT REDUCTION;

EPHEDRA SINICA; EPHEDRACEAE; LAMINARIA JAPONICA; LAMINARIACEAE; MUS; POLYGONACEAE; RHEUM PALMATUM; RODENTIA;

EID: 84863284753     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2011.618502     Document Type: Article

References (35)

1. Ahn IS, Do MS, Choi BH, Kong CS, Kim SO, Han MS, Park KY. (2006). Reduced leptin secretion by fucoidan-added Kochujang and anti-adipogenic effect of fucoidan in mouse 3T3-L1 adipocytes. J Food Sci 11:31-35.
2. Aoyama T, Peters JM, iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ. (1998). Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem, 273, 5678-5684. (Pubitemid 28124039)
3. Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, Strauss R, Meredith T. (2002). Herbal ephedra/cafeine for weight loss: A 6-month randomized safety and efcacy trial. Int J Obes Relat Metab Disord, 26, 593-604. (Pubitemid 34499277)
4. Boozer CN, Nasser JA, Heymsfeld SB, Wang V, Chen G, Solomon JL. (2001). An herbal supplement containing Ma Huang-Guarana for weight loss: A randomized, double-blind trial. Int J Obes Relat Metab Disord, 25, 316-324. (Pubitemid 32209805)
5. Carling D. (2004). The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem Sci, 29, 18-24. (Pubitemid 38068476)
6. Colberg SR, Simoneau JA, Taete FL, Kelley DE. (1995). Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest, 95, 1846-1853.
7. Collier CA, Bruce CR, Smith AC, Lopaschuk G, Dyck DJ. (2006). Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle. Am J Physiol Endocrinol Metab, 291, E182-E189. (Pubitemid 44035324)
8. Fleming RM. (2008). Safety of ephedra and related anorexic medications. Expert Opin Drug Saf, 7, 749-759.
9. Gao Y, Zhou Y, Xu A, Wu D. (2008). Effects of an AMP-activated protein kinase inhibitor, compound C, on adipogenic diferentiation of 3T3-L1 cells. Biol Pharm Bull, 31, 1716-1722.
10. Haller CA, Benowitz NL. (2000). Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med, 343, 1833-1838. (Pubitemid 32104128)
11. Hardie DG. (2008). AMPK: A key regulator of energy balance in the single cell and the whole organism. Int J Obes (Lond), 32 Suppl 4, S7-12.
12. Hardie DG, Carling D, Carlson M. (1998). The AMP-activated/SNF1 protein kinase subfamily: Metabolic sensors of the eukaryotic cell? Annu Rev Biochem, 67, 821-855. (Pubitemid 28411146)
13. Hardie DG, Hawley SA, Scott JW. (2006). AMP-activated protein kinase-development of the energy sensor concept. J Physiol (Lond), 574, 7-15. (Pubitemid 43905792)
14. Huang L, Wen K, Gao X, Liu Y. (2010). Hypolipidemic effect of fucoidan from Laminaria japonica in hyperlipidemic rats. Pharm Biol, 48, 422-426.
15. Jeong S, Han M, Lee H, Kim M, Kim J, Nicol CJ, Kim BH, Choi JH, Nam KH, Oh GT, Yoon M. (2004). Effects of fenofbrate on high-fat diet-induced body weight gain and adiposity in female C57BL/6J mice. Metab Clin Exp, 53, 1284-1289. (Pubitemid 39222088)
16. Kemp BE, Mitchelhill Ki, Stapleton D, Michell BJ, Chen Z P, Witters LA. (1999). Dealing with energy demand: The AMP-activated protein kinase. Trends Biochem Sci, 24, 22-25. (Pubitemid 29074459)
17. Kroetz DL, Yook P, Costet P, Bianchi P, Pineau T. (1998). Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes. J Biol Chem, 273, 31581-31589. (Pubitemid 28533182)
18. Lee WJ, Kim M, Park HS, Kim HS, Jeon MJ, Oh KS, Koh EH, Won JC, Kim MS, Oh GT, Yoon M, Lee KU, Park JY. (2006). AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPAR-alpha and PGC-1. Biochem Biophys Res Commun, 340, 291-295. (Pubitemid 41827679)
19. Lee Y, Yu X, Gonzales F, Mangelsdorf DJ, Wang MY, Richardson C, Witters LA, Unger RH. (2002). PPAR alpha is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue. Proc Natl Acad Sci USA, 99, 11848-11853. (Pubitemid 34994487)
20. Liu JF, Ma Y, Wang Y, Du ZY, Shen JK, Peng HL. (2011). Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress. Phytother Res, 25, 588-596.
21. Long YC, Zierath JR. (2006). AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest, 116, 1776-1783. (Pubitemid 44033297)
22. López-Soriano J, Chiellini C, Mafei M, Grimaldi PA, Argilés JM. (2006). Roles of skeletal muscle and peroxisome proliferator-activated receptors in the development and treatment of obesity. Endocr Rev, 27, 318-329.
23. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH. (1997). Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes, 46, 983-988. (Pubitemid 27220998)
24. Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE. (1999). Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J, 13, 2051-2060. (Pubitemid 29517635)
25. Suzuki A, Okamoto S, Lee S, Saito K, Shiuchi T, Minokoshi Y. (2007). Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase. Mol Cell Biol, 27, 4317-4327. (Pubitemid 46906556)
26. Xue B, Kahn BB. (2006). AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J Physiol (Lond), 574, 73-83. (Pubitemid 43905798)
27. Xue J, Ding W, Liu Y. (2010). Anti-diabetic effects of emodin involved in the activation of PPARgamma on high-fat diet-fed and low dose of streptozotocin-induced diabetic mice. Fitoterapia, 81, 173-177.
28. Yan ZH, Karam WG, Staudinger JL, Medvedev A, Ghanayem Bi, Jetten AM. (1998). Regulation of peroxisome proliferator-activated receptor alpha-induced transactivation by the nuclear orphan receptor TAK1/TR4. J Biol Chem, 273, 10948-10957. (Pubitemid 28204934)
29. Yoon M. (2009). The role of PPARalpha in lipid metabolism and obesity: Focusing on the effects of estrogen on PPARalpha actions. Pharmacol Res, 60, 151-159.
30. Yoon M. (2010). PPARa in obesity: sex diference and estrogen involvement. PPAR Res, 2010, 584296.
31. Yoon KH, Lee HY, Jung YS, Seo Bi, Park KY, Yoon M, Shin SS. (2010). Modulation of obesity by Gyeongshingangjeehwan 18 in ob/ob mice. Kor J Herbology 25:1-9.
32. You JS, Sung MJ, Chang KJ. (2009). Evaluation of 8-week body weight control program including sea tangle (Laminaria japonica) supplementation in Korean female college students. Nutr Res Pract, 3, 307-314.
33. Zarain-Herzberg A, Rupp H. (2002). Terapeutic potential of CPT i inhibitors: Cardiac gene transcription as a target. Expert Opin Investig Drugs, 11, 345-356. (Pubitemid 34213389)
34. Zheng CD, Duan YQ, Gao JM, Ruan ZG. (2010). Screening for anti-lipase properties of 37 traditional Chinese medicinal herbs. J Chin Med Assoc, 73, 319-324.
35. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. (2001). Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest, 108, 1167-1174. (Pubitemid 32995375)